AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at the 46th Annual TD Cowen Health Care Conference at 1:10 p.m. ET on Monday, March 2, 2026. Senior VPs Kave Niksefat (Global Marketing and Access) and Justin Claeys (Finance) will speak.

The presentation will be webcast live and archived for at least 90 days on Amgen's Investor Relations events calendar and webcast page, available to media, investors and the public.

Key Figures

Conference number: 46th Annual Presentation time: 1:10 p.m. ET Presentation date: March 2, 2026 +1 more

4 metrics

Conference number 46th Annual TD Cowen Health Care Conference edition

Presentation time 1:10 p.m. ET Scheduled time on March 2, 2026

Presentation date March 2, 2026 TD Cowen Health Care Conference

Webcast archive period 90 days Replay availability after the event

Market Reality Check

Price: $382.87 Vol: Volume 2,926,146 vs 20-da...

normal vol

$382.87 Last Close

Volume Volume 2,926,146 vs 20-day average 3,067,710 (relative volume 0.95x) shows typical trading ahead of this conference notice. normal

Technical Shares at $379.42 are trading above the 200-day MA of $307.50 and sit 1.48% below the 52-week high of $385.12.

Peers on Argus

AMGN gained 1.25% while large-cap peers were mixed: PFE +1.90%, GILD +0.61%, BMY...

AMGN gained 1.25% while large-cap peers were mixed: PFE +1.90%, GILD +0.61%, BMY +0.46%, SNY +0.25%, and GSK roughly flat at -0.02%, pointing to stock-specific strength rather than a uniform sector move.

Historical Context

5 past events · Latest: Feb 13 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 13	Conference presentation	Neutral	+1.1%	Announcement of Citi 2026 Virtual Oncology Summit webcast access.
Feb 03	Earnings results	Positive	-1.8%	Reported 2025 revenue and EPS growth with mixed product performance.
Jan 28	Earnings webcast	Neutral	+0.2%	Scheduled Q4 and full-year 2025 results call and webcast details.
Jan 20	Legal dispute	Negative	+0.2%	Lawsuit filed by nonprofit over prescription drug access issues.
Jan 07	Conference presentation	Neutral	-3.4%	J.P. Morgan Healthcare Conference presentation and webcast information.

Pattern Detected

Recent Amgen headlines around conferences and webcasts have usually seen modest moves, while earnings and legal or strategic items have produced more mixed and sometimes contrary reactions.

Recent Company History

Over the past few months, Amgen has mixed routine investor events with more material updates. Webcasts and conference presentations on Jan 7 and Feb 13 saw limited single-day impacts despite visibility. Earnings-related items around Feb 3 delivered strong 2025 revenue and EPS growth but drew a negative next-day move. A lawsuit-related headline on Jan 20 coincided with only a small gain. Today’s conference appearance fits the pattern of ongoing investor outreach rather than a discrete financial or clinical catalyst.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2026-02-13

Amgen has an effective automatic shelf registration on Form S-3ASR dated 2026-02-13, allowing issuance of various securities and resale of common stock by selling securityholders. The shelf has already been used in at least 2 recent prospectus supplements (424B2 and 424B3) to support senior notes offerings.

Market Pulse Summary

This announcement highlights a scheduled Amgen presentation at the TD Cowen Health Care Conference, ...

Analysis

This announcement highlights a scheduled Amgen presentation at the TD Cowen Health Care Conference, with a webcast at 1:10 p.m. ET on March 2, 2026 and replay access for at least 90 days. It fits a pattern of regular investor outreach via conferences and webcasts. Against a backdrop of recent earnings, debt issuance under an automatic shelf, and multiple SEC filings, investors may focus more on any incremental strategic commentary delivered at the event than on the logistics themselves.

AI-generated analysis. Not financial advice.

THOUSAND OAKS, Calif., Feb. 24, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 46^th Annual TD Cowen Health Care Conference at 1:10 p.m. ET on Monday, March 2, 2026. Kave Niksefat, senior vice president of Global Marketing and Access at Amgen, and Justin Claeys, senior vice president of Finance at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. 

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. 

About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines. 

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases and obesity and obesity-related conditions.

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average^®, and it is also part of the Nasdaq-100 Index^®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads. 

CONTACT: Amgen, Thousand Oaks 
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-46th-annual-td-cowen-health-care-conference-302696171.html

SOURCE Amgen

FAQ

When will Amgen (AMGN) present at the 46th Annual TD Cowen Health Care Conference?

Amgen will present on Monday, March 2, 2026 at 1:10 p.m. ET. According to Amgen, the session features senior management and will be webcast live for investors, media and the public and archived for later replay.

Who from Amgen (AMGN) will speak at the TD Cowen conference on March 2, 2026?

Kave Niksefat and Justin Claeys will present for Amgen at the conference. According to Amgen, Niksefat is senior vice president of Global Marketing and Access and Claeys is senior vice president of Finance.

How can investors watch the Amgen (AMGN) webcast from the TD Cowen conference?

Investors can watch the live webcast on Amgen's Investor Relations website. According to Amgen, the webcast link and event time are posted on the company's events calendar and accessible to the public online.

Will the Amgen (AMGN) TD Cowen presentation be available after the live event?

Yes, the webcast will be archived and available for replay for at least 90 days after the event. According to Amgen, the archived recording will remain on the Investor Relations webcast page for on-demand access.

What topics will Amgen (AMGN) cover during the TD Cowen Health Care Conference presentation?

The company will cover recent business developments and investor-focused topics during the presentation. According to Amgen, management presentations at investor conferences typically address strategy, access and financial perspectives relevant to investors.